Status:
ENROLLING_BY_INVITATION
An Intergenerational, Cognitively Enriched Intervention for MCI Patients and Their Children.
Lead Sponsor:
University Ghent
Collaborating Sponsors:
University Hospital, Ghent
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
Phase:
NA
Brief Summary
In 2018, approximately 50 million people received a diagnosis of dementia, which is projected to triple by 2050. To mitigate the increase in dementia, it is crucial to prevent cognitive decline in at ...
Detailed Description
In 2018, approximately 50 million people received a diagnosis of dementia, which is projected to triple by 2050. To mitigate the increase in dementia, it is crucial to prevent cognitive decline in at ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- MCI Diagnosis: Individuals with mild cognitive impairment (MCI) are eligible to participate, without a formal dementia diagnosis.
- MCI Type: Both amnestic and non-amnestic MCI individuals qualify for participation.
- Adult Child: Must have an adult child willing to participate in the program, free from serious health issues, both physically and cognitively.
- Exclusion criteria:
- Dementia Diagnosis: Individuals formally diagnosed with dementia cannot participate.
- MCI from Specific Causes: Excludes those with MCI caused by frontotemporal dementia or Parkinson's.
Exclusion
Key Trial Info
Start Date :
September 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06221579
Start Date
September 13 2023
End Date
September 30 2025
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University
Ghent, Belgium, 9000